Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Azilsartan-d4

Azilsartan-d4 is the deuterium labeled Azilsartan[1]. Azilsartan is an orally active, potent, selective and specific angiotensin II type 1 receptor (AT1) antagonist. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity. Azilsartan can be used for hypertension and stroke research[2][3][4][5][6].

Product Specifications

CAS Number

1794817-45-0

Product Name Alternative

TAK-536-d4

UNSPSC

12352005

Target

Angiotensin Receptor; Apoptosis; Reactive Oxygen Species (ROS)

Type

Isotope-Labeled Compounds

Related Pathways

Apoptosis; GPCR/G Protein; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Cancer

Solubility

10 mM in DMSO

Smiles

CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=C([2H])C([2H])=C(C4=C(C5=NOC(N5)=O)C=CC=C4)C([2H])=C3[2H]

Molecular Formula

C25H16D4N4O5

Molecular Weight

460.47

References & Citations

[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53 (2) :211-216.|[2]Kajiya T, et al. Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker. J Hypertens. 2011 Dec;29 (12) :2476-83.|[3]Zhao M, et al. Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats. Diabetes Obes Metab. 2011 Dec;13 (12) :1123-9.|[4]Ojima M, et al. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies. J Pharmacol Exp Ther. 2011 Mar;336 (3) :801-8.|[5]Gupta V, et al. Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms. Neurochem Int. 2020 Jan;132:104604.|[6]Ahmadian E, et al. Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2. Biomed Pharmacother. 2018 Mar;99:939-946.

Shipping Conditions

Room temperature

Scientific Category

Isotope-Labeled Compounds

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Penta-2,4-dienoic Acid
TRC-P268363-500MG 500 mg

Penta-2,4-dienoic Acid

Sign In for Pricing
View Details
LNK (SH2B3) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2C9]
TA502933AM 100 µL

LNK (SH2B3) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI2C9]

Sign In for Pricing
View Details
Human GEN1 activation kit by CRISPRa
GA117684 1 Kit

Human GEN1 activation kit by CRISPRa

Sign In for Pricing
View Details
SLC38A9 Human qPCR Primer Pair (NM_173514)
HP218334 200 Reactions

SLC38A9 Human qPCR Primer Pair (NM_173514)

Sign In for Pricing
View Details
Cytokeratin, Basic (Type II or HMW) (KRTH/2147R), CF594 conjugate, 0.1mg/mL
BNC942147-100 1x 100 µL

Cytokeratin, Basic (Type II or HMW) (KRTH/2147R), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Human Nuclear Antigen (NM106), CF405S conjugate, 0.1mg/mL
BNC040106-100 1x 100 µL

Human Nuclear Antigen (NM106), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details